High-risk gestational trophoblastic neoplasia with brain metastases: individualized multidisciplinary therapy in the management of four patients.
暂无分享,去创建一个
[1] D. Correa,et al. Delayed neurotoxicity in primary central nervous system lymphoma. , 2005, Archives of neurology.
[2] J. Benedet,et al. Gestational trophoblastic neoplasia, FIGO 2000 staging and classification , 2003, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[3] R. Soffietti,et al. Management of brain metastases , 2002, Journal of Neurology.
[4] G. Rustin,et al. Management of brain metastases in patients with high-risk gestational trophoblastic tumors. , 2002, The Journal of reproductive medicine.
[5] J. Doroshow,et al. Pharmacokinetics and toxicity of high-dose intravenous methotrexate in the treatment of leptomeningeal carcinomatosis , 2000, Cancer Chemotherapy and Pharmacology.
[6] R. Coleman,et al. Gestational trophoblastic disease: does central nervous system chemoprophylaxis have a role? , 1999, British Journal of Cancer.
[7] J. Blay,et al. High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] B. Mychalczak,et al. Prognosis of patients treated with whole-brain radiation therapy for metastatic gestational trophoblastic disease. , 1998, Gynecologic oncology.
[9] W. Small,et al. Gestational trophoblastic disease metastatic to the brain. , 1996, Radiology.
[10] E. Newlands,et al. Gestational choriocarcinoma metastatic to the brain treated successfully by stereotactic radiosurgery and chemotherapy. , 1996, Clinical oncology (Royal College of Radiologists (Great Britain)).
[11] A. Berchuck,et al. Gestational trophoblastic disease metastatic to the central nervous system. , 1995, Gynecologic oncology.
[12] A. Karim. Stereotactic irradiations on the horizon: a challenge for multimodal developments. , 1994, International journal of radiation oncology, biology, physics.
[13] A. Berchuck,et al. Alternating weekly chemotherapy with etoposide‐methotrexatedactinomycin/cyclophosphamide‐vincristine for high‐risk gestational trophoblastic disease , 1994, Obstetrics and gynecology.
[14] B. O'neill,et al. Delayed leukoencephalopathy in survivors with small cell lung cancer , 1987, Neurology.